Dr Woods is analysing thousands of GP records to see whether people who later developed pancreatic cancer shared similar early warning signs detectable before diagnosis.
Dr Walsh aims to design chemotherapy drugs that will target and kill types of cancer stem cells within pancreatic tumours that are responsible for drug resistance and relapse.
Professor Hallden is researching how to use a flu-like virus to seek out and infect pancreatic cancer cells wherever they are in the body.
Dr Clarkson's research focuses on c-FLIP, a molecule found in pancreatic cancer cells that stops damaged or diseased cells from dying.
Prof Lowery will study tumour samples to find changes in genes and assess whether these changes affect how patients respond to drugs.
Professor Kocher’s project will investigate why immunotherapy - a treatment which harnesses the patient’s immune system to kill cancer cells - doesn't work with pancreatic cancer.
In a project co-funded with Worldwide Cancer Research, Dr Cameron aims to prevent normal cells in the pancreas from supporting pancreatic cancer growth and resistance to cancer treatments.
This new project will investigate the exact role of the molecule avb8 which sits on the cell surface of many types of pancreatic cancer.
Professor Friend and Mr Srikanth Reddy will conduct a pilot study to treat 20 pancreatic cancer patients who are not eligible for surgery with high intensity focused ultrasound.
Dr Wells will investigate the interaction between two proteins called PAK4 and p85 which she believes helps pancreatic cancer to spread.